Ropes & Gray Advises Avista Capital Partners on MSEK 3,400 Sale of Trimb to Karo Pharma

In The News
June 21, 2019

Ropes & Gray has advised Avista Capital Partners on the sale of Trimb, a leading consumer healthcare company based in Stockholm, Sweden, to Karo Pharma for MSEK 3,400. Avista Capital Partners - an American healthcare-focused private equity firm - is a long-time client of Ropes & Gray, but this deal is the first time it has been advised by the firm’s London team.

Founded in 2012, Trimb owns licenses to, markets and sells a large number of over-the-counter pharmaceuticals and consumer healthcare products across Northern Europe. Over the last five years, Trimb has completed several strategic acquisitions and executed a number of organic growth initiatives and has a portfolio of leading brands focused on skin care, foot care, oral care and intimate health categories.

The transaction is subject to customary competition authority approvals being received. 

The Ropes & Gray team, all based in London, was led by private equity partner Helen Croke. Other members of the team included private equity associates Laura Kayani and Craig Jourdan alongside antitrust partner Ruchit Patel and antitrust associate Rupert Phillips. It is the first time that Ropes & Gray’s London team has advised Avista Capital Partners.